SIRT4 and prostate carcinoma: In addition, the PAK6-SIRT4-ANT2 complex inhibited apoptosis in prostate cancer cells, and SIRT4 deprived ANT2 acetylation at the K105 site and promoted ubiquitinated degradation of ANT2.